HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 713, Issue 1-2, 2011, Pages 1-7

  Yin, Jiaoyang ^a   Vogel, Ulla ^b   Ma, Yegang ^c   Qi, Rong ^a   Wang, Huiwen ^a   Yue, Li ^d   Liang, Duohong ^a   Wang, Chunhong ^a   Li, Xinxin ^a   Song, Tiehua ^a  

^a SHENYANG MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^d JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese population; ERCC1 and ERCC2; HapMap database; HtSNP; Lung cancer susceptibility

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, GENETIC; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 79960264883     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.05.003     Document Type: Article

References (37)

1. Lam W.K., White N.W., Chan-Yeung M.M. Lung cancer epidemiology and risk factors in Asia and Africa. Int. J. Tuberc. Lung Dis. 2004, 8:1045-1057.
2. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., Bukowy Z., Wallin H., Overvad K., Tjønneland A., Nexø B.A., Raaschou-Nielsen O. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat. Res. 2004, 546:65-74.
3. Chen Z. Medical Genetics 2001, People Hygienic Press, Beijing, pp. 262-263. 1st ed.
4. Vineis P., Manuguerra M., Kavvoura F.K., Guarrera S., Allione A., Rosa F., Di Gregorio A., Polidoro S., Saletta F., Ioannidis J.P., Matullo G. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst. 2009, 101:24-36.
5. Kiyohara C., Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int. J. Med. Sci. 2007, 4:59-71.
6. Staresincic L., Fagbemi A.F., Enzlin J.H., Gourdin A.M., Wijgers N., Dunand-Sauthier I., Giglia-Mari G., Clarkson S.G., Vermeulen W., Schärer O.D. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J. 2009, 28:1111-1120.
7. Rockenbauer E., Bendixen M.H., Bukowy Z., Yin J., Jacobsen N.R., Hedayati M., Vogel U., Grossman L., Bolund L., Nexø B.A. Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts. Carcinogenesis 2002, 23:1149-1153.
8. Yin J., Rockenbauer E., Hedayati M., Jacobsen N.R., Vogel U., Grossman L., Bolund L., Nexø B.A. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1449-1453.
9. Yin J., Vogel U., Gerdes L.U., Dybdahl M., Bolund L., Nexo B.A. Twelve single nucleotide polymorphisms on chromosome 19q13.2-13.3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients. Biochem. Genet. 2003, 41:27-37.
10. Sturgis E.M., Dahlstrom K.R., Spitz M.R., Wei Q. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 2002, 128:1084-1088.
11. Nexø B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., Wallin H., Overvad K., Tjønneland A. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 2003, 24:899-904.
12. Matullo G., Dunning A.M., Guarrera S., Baynes C., Polidoro S., Garte S., Autrup H., Malaveille C., Peluso M., Airoldi L., Veglia F., Gormally E., Hoek G., Krzyzanowski M., Overvad K., Raaschou-Nielsen O., Clavel-Chapelon F., Linseisen J., Boeing H., Trichopoulou A., Palli D., Krogh V., Tumino R., Panico S., Bueno-De-Mesquita H.B., Peeters P.H., Lund E., Pera G., Martinez C., Dorronsoro M., Barricarte A., Tormo M.J., Quiros J.R., Day N.E., Key T.J., Saracci R., Kaaks R., Riboli E.P. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006, 27:997-1007.
13. Wrensch M., Kelsey K.T., Liu M., Miike R., Moghadassi M., Sison J.D., Aldape K., McMillan A., Wiemels J., Wiencke K. ERCC1 and ERCC2 polymorphisms and adult glioma. Neurooncology 2005, 7:495-507.
14. Yang Z.H., Dai Q., Kong X.L., Yang W.L., Zhang L. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol. Carcinog. 2009, 48:196-201.
15. Pan J., Lin J., Izzo J.G., Liu Y., Xing J., Huang M., Ajani J.A., Wu X. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009, 30:785-792.
16. Zhou W., Liu G., Park s., Wang Z., Wain J.C., Lynch T.J., Su L., Christian D.C. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:491-496.
17. Pittman A.M., Myers A.J., Abou-Sleiman P., Fung H.C., Kaleem M., Marlowe L., Duckworth J., Leung D., Williams D., Kilford L., Thomas N., Morris C.M., Dickson D., Wood N.W., Hardy J., Lees A.J., de Silva R. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 2005, 42:837-846.
18. Benusiglio P.R., Lesueur F., Luccarini C., McIntosh J., Luben R.N., Smith P., Dunning A., Easton D.F., Ponder B.A., Pharoah P.D. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs. BMC Cancer 2005, 5:81.
19. The International HapMap Consortium, A haplotype map of the human genome. Nature 2005, 437:1299-1320.
20. The International HapMap Consortium, a second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
21. Hu Z., Xu L., Shao M., Yuan J., Wang Y., Wang F., Yuan W., Qian J., Ma H., Wang Y., Liu H., Chen W., Yang L., Jing G., Huo X., Chen F., Jin L., Wei Q., Wu T., Lu D., Huang W., Shen H. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1336-1340.
22. Ma H., Xu L., Yuan J., Shao M., Hu Z., Wang F., Wang Y., Yuan W., Qian J., Wang Y., Xun P., Liu H., Chen W., Yang L., Jin G., Huo X., Chen F., Shugart Y.Y., Jin L., Wei Q., Wu T., Shen H., Huang W., Lu D. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population. Pharmacogenet. Genomics 2007, 17:417-423.
23. Yin J., Vogel U., Ma Y., Qi R., Wang H. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population. Carcinogenesis 2009, 30:1181-1185.
24. Yin J., Vogel U., Guo L., Ma Y., Wang H. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet. Cytogenet. 2006, 164:66-70.
25. Xiao Z., Xiao J., Jiang Y., Zhang S., Yu M., Zhao J., Wei D., Cao H. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol. Res. 2006, 34:150-155.
26. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
27. Vogel U, Nexø B.A., Tjønneland A., Wallin H., Hertel O., Raaschou-Nielsen O. ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutat. Res. 2006, 593:88-96.
28. Saebø M., Skjelbred C.F., Nexø B.A., Wallin H., Hansteen I.L., Vogel U., Kure E.H. Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas. BMC Cancer 2006, 6:208.
29. Nexø B.A., Vogel U., Olsen A., Nyegaard M., Bukowy Z., Rockenbauer E., Zhang X., Koca C., Mains M., Hansen B., Hedemand A., Kjeldgaard A., Laska M.J., Raaschou-Nielsen O., Cold S., Overvad K., Tjønneland A., Bolund L., Børglum A.D. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP. BMC Med. Genet. 2008, 9:56.
30. Schierup M.H., Mailund T., Li H., Wang J., Tjønneland A., Vogel U., Bolund L., Nexø B.A. Haplotype frequencies in a sub-region of chromosome 19q13.3, related to risk and prognosis of cancer, differ dramatically between ethnic groups. BMC Med. Genet. 2009, 10:20.
31. Vangsted A., Gimsing P., Klausen T.W., Nexø B.A., Wallin H., Andersen P., Hokland P., Lillevang S.T., Vogel U. Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation. Int. J. Cancer 2007, 120:1036-1045.
32. Vogel U., Dybdahl M., Frentz G., Nexo B.A. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat. Res. 2000, 46:197-210.
33. Vogel U., Sørensen M., Hansen R.D., Tjønneland A., Overvad K., Wallin H., Nexø B.A., Raaschou-Nielsen O. Gene-environment interactions between smoking and a haplotype of RAI, ASE-1 and ERCC1 polymorphisms among women in relation to risk of lung cancer in a population-based study. Cancer Lett. 2007, 247:159-165.
34. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair gene and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
35. Wang Y., Broderick P., Webb E., Wu X., Vijayakrishnana J., Matakidou A., Qureshi M.M., Dong Q., Gu X., Chen W.V., Spitz M.R., Eisen T., Amos C.T., Houlston R.S. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 2008, 40:1407-1409.
36. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., Phillips D.H., Canzian F., Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27:560-567.
37. Vogel U., Olsen A., Wallin H., Overvad K., Tjønneland A., Nexø B.A. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect. Prev. 2005, 29:209-214.